Filing Details
- Accession Number:
- 0000905148-24-000585
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-12 21:45:35
- Reporting Period:
- 2024-02-08
- Accepted Time:
- 2024-02-12 21:45:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1439725 | Biodesix Inc | BDSX | Services-Medical Laboratories (8071) | 203986492 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1828131 | Kieran O'kane | 919 West Dillon Rd Louisville CO 80027 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-08 | 32,024 | $0.00 | 79,736 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-09 | 6,319 | $1.92 | 73,417 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-12 | 5,412 | $1.66 | 68,005 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2024-02-08 | 64,381 | $0.00 | 64,381 | $0.00 |
| Common Stock | Stock Options (Right to buy) | Acquisiton | 2024-02-08 | 128,761 | $0.00 | 128,761 | $1.99 |
| Common Stock | Restricted Stock Units | Disposition | 2024-02-08 | 1,490 | $0.00 | 1,490 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-02-08 | 30,534 | $0.00 | 30,534 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 64,381 | No | 4 | A | Direct | ||
| 128,761 | 2034-02-07 | No | 4 | A | Direct | |
| 11,915 | No | 4 | M | Direct | ||
| 91,601 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.8191 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
- This option vests in a series of forty-eight successive equal monthly installments measured from January 15, 2024, generally subject to the Reporting Person's continuous service through each applicable vesting date.
- These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
- These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Billionaire Hedge Funds
